REGENACY PHARMACEUTICALS
Regenacy Pharmaceuticals they give services to treat diabetic and other peripheral neuropathies.
REGENACY PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical Service Industry Therapeutics
Founded:
2016-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.regenacy.com
Total Employee:
1+
Status:
Active
Contact:
(617) 415-5030
Email Addresses:
[email protected]
Total Funding:
17.11 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Global Site Tag Microsoft Exchange Online Office 365 Mail
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Valitor
Valitor has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacological properties..
Current Advisors List
Current Employees Featured
Founder
Investors List
Cobro Ventures
Cobro Ventures investment in Series B - Regenacy Pharmaceuticals
Taiwania Capital Management Corporation
Taiwania Capital Management Corporation investment in Series B - Regenacy Pharmaceuticals
Yonjin Venture
Yonjin Venture investment in Series B - Regenacy Pharmaceuticals
3E Bioventures
3E Bioventures investment in Series B - Regenacy Pharmaceuticals
3E Bioventures
3E Bioventures investment in Series A - Regenacy Pharmaceuticals
Taya Ventures
Taya Ventures investment in Series A - Regenacy Pharmaceuticals
Cobro Ventures
Cobro Ventures investment in Series A - Regenacy Pharmaceuticals
Taiwania Capital Management Corporation
Taiwania Capital Management Corporation investment in Series A - Regenacy Pharmaceuticals
Rivas Capital
Rivas Capital investment in Series A - Regenacy Pharmaceuticals
Viva Biotech
Viva Biotech investment in Series A - Regenacy Pharmaceuticals
Official Site Inspections
http://www.regenacy.com Semrush global rank: 3.23 M Semrush visits lastest month: 5.15 K
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Regenacy Pharmaceuticals"
Regenacy Pharmaceuticals - Crunchbase Company Profile & Funding
Regenacy Pharmaceuticals Provides Healthcare Services. View contacts for Regenacy Pharmaceuticals to access new leads and connect with decision-makers. Regenacy …See details»
Regenacy Pharmaceuticals Announces Collaboration with the …
Regenacy Pharmaceuticals - Overview, News & Similar companies ...
Aug 24, 2022 · View Regenacy Pharmaceuticals (www.regenacy.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well …See details»
Organization | Regenacy Pharmaceuticals LLC
Regenacy Pharmaceuticals LLC Report issue For profit Phase 2 Founded: Boston MA United States (2016)See details»
Regenacy Pharmaceuticals, Inc. | LinkedIn
Regenacy Pharmaceuticals, Inc. | 376 followers on LinkedIn. Regenacy Pharmaceuticals is developing a novel, disease-modifying approach to treating peripheral neuropathies that goes beyond pain...See details»
Regenacy Pharmaceuticals - PitchBook
Developer of therapeutic drugs based on the novel, disease-modifying approach intended for the treatment of peripheral neuropathy.See details»
Regenacy Pharmaceuticals Company Profile - Office Locations
Regenacy Pharmaceuticals is a company that develops therapeutic drugs created to treat peripheral neuropathy. It focuses on the development of ricolinostat, an orally bioavailable …See details»
Regenacy Pharmaceuticals - Contacts, Employees, Board …
Regenacy Pharmaceuticals has 5 current employee profiles, including Co-Founder & Executive Chairman Marc Cohen. Regenacy Pharmaceuticals has 1 board member or advisor, Walter …See details»
Regenacy Pharmaceuticals - Funding, Financials, Valuation
Regenacy Pharmaceuticals is funded by 7 investors. Cobro Ventures and Taiwania Capital Management Corporation are the most recent investors. Which investors participated in the …See details»
Regenacy Pharmaceuticals - Regulatory and Advisory Team - The …
The Regulatory and Advisory Team at Regenacy Pharmaceuticals is responsible for ensuring compliance with regulatory standards throughout the drug development process. This team …See details»
Regenacy Pharmaceuticals - VentureRadar
Regenacy Pharmaceuticals is developing a novel, disease-modifying approach to treating peripheral neuropathies that goes beyond pain and symptom management to restore …See details»
Regenacy Pharmaceuticals Raises $30 Million in Series A Financing
Mar 25, 2020 · WALTHAM, Mass.-- ( BUSINESS WIRE )-- Regenacy Pharmaceuticals, a clinical-stage biopharmaceutical company developing breakthrough treatments for diabetic and other …See details»
Regenacy is poised to deliver the first treatment for ... - Nature
Regenacy Pharmaceuticals is developing a novel, disease-modifying approach to treating peripheral neuropathies that goes beyond pain and symptom management to restore …See details»
Regenacy is poised to deliver the first treatment for ... - Nature
Regenacy Pharmaceuticals is developing a novel, disease-modifying approach to treating peripheral neuropathies that goes beyond pain and symptom management to restore …See details»
Regenacy Announces the Formation of a Joint Venture with 3E …
Dec 21, 2020 · Regenacy Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company regenerating biological function by protein acetylation for the treatment of diabetic and other …See details»
Regenacy Pharmaceuticals Announces Completion of Enrollment …
Aug 24, 2022 · Regenacy Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company regenerating biological function by protein acetylation for the treatment of diabetic and other …See details»
Regenacy Announces the Formation of a Joint Venture with 3E …
Dec 21, 2020 · Regenacy Pharmaceuticals, a clinical-stage biopharmaceutical company developing breakthrough treatments for diabetic and other peripheral neuropathies, and 3E …See details»
Regenacy Pharmaceuticals Raises $30 Million in Series A Financing
Regenacy Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company regenerating biological function by protein acetylation for the treatment of diabetic and other peripheral …See details»
Regenacy Pharmaceuticals Announces Completion of Enrollment …
Regenacy Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company regenerating biological function by protein acetylation for the treatment of diabetic and other peripheral …See details»
Regenacy Pharmaceuticals to be Launched by Acetylon …
Dec 2, 2016 · Regenacy will receive exclusive worldwide rights to Acetylon’s Phase 2 selective histone deacetylase 6 (HDAC6) inhibitor, ricolinostat (ACY-1215), for the treatment of certain …See details»